Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
- DOI
- 10.1016/j.htct.2020.09.112
- Published
- 10
- Container
- Hematology, Transfusion and Cell Therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.htct.2020.09.112,
title = {Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura},
author = {L. Kaynar and P. Coppo and M. Scully and J. De La Rubia and F. Peyvandi and S. Cataland and J. A. Kremer Hovinga and P. Knoebl and K. Pavenski and J. Minkue Mi Edou and F. Callewaert and R. De Passos Sousa},
year = {2020},
journal = {Hematology, Transfusion and Cell Therapy},
doi = {10.1016/j.htct.2020.09.112},
url = {https://doi.org/10.1016/j.htct.2020.09.112}
}RIS
TY - JOUR TI - Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura AU - L. Kaynar AU - P. Coppo AU - M. Scully AU - J. De La Rubia AU - F. Peyvandi AU - S. Cataland AU - J. A. Kremer Hovinga AU - P. Knoebl AU - K. Pavenski AU - J. Minkue Mi Edou AU - F. Callewaert AU - R. De Passos Sousa PY - 2020 JO - Hematology, Transfusion and Cell Therapy DO - 10.1016/j.htct.2020.09.112 UR - https://doi.org/10.1016/j.htct.2020.09.112 ER -
APA
Kaynar, L., Coppo, P., Scully, M., Rubia, J. D. L., Peyvandi, F., Cataland, S., Hovinga, J. A. K., Knoebl, P., Pavenski, K., Edou, J. M. M., Callewaert, F., & Sousa, R. D. P. (2020). Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura. Hematology, Transfusion and Cell Therapy. https://doi.org/10.1016/j.htct.2020.09.112
Source records
- doaj · retrieved 2026-09-26T18:12:52.290Z